Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1951 1
1952 2
1955 3
1957 8
1958 8
1959 12
1960 14
1961 9
1962 12
1963 13
1964 8
1965 5
1974 1
1981 2
1986 7
1987 30
1988 29
1989 39
1990 55
1991 43
1992 39
1993 29
1994 39
1995 56
1996 36
1997 42
1998 54
1999 34
2000 38
2001 46
2002 29
2003 41
2004 46
2005 63
2006 50
2007 36
2008 57
2009 51
2010 68
2011 64
2012 66
2013 89
2014 67
2015 84
2016 84
2017 87
2018 74
2019 81
2020 86
2021 95
2022 92
2023 76
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

2,008 results

Results by year

Filters applied: . Clear all
Page 1
Oxalate homeostasis.
Ermer T, Nazzal L, Tio MC, Waikar S, Aronson PS, Knauf F. Ermer T, et al. Nat Rev Nephrol. 2023 Feb;19(2):123-138. doi: 10.1038/s41581-022-00643-3. Epub 2022 Nov 3. Nat Rev Nephrol. 2023. PMID: 36329260 Free PMC article. Review.
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope.
Groothoff JW, Metry E, Deesker L, Garrelfs S, Acquaviva C, Almardini R, Beck BB, Boyer O, Cerkauskiene R, Ferraro PM, Groen LA, Gupta A, Knebelmann B, Mandrile G, Moochhala SS, Prytula A, Putnik J, Rumsby G, Soliman NA, Somani B, Bacchetta J. Groothoff JW, et al. Nat Rev Nephrol. 2023 Mar;19(3):194-211. doi: 10.1038/s41581-022-00661-1. Epub 2023 Jan 5. Nat Rev Nephrol. 2023. PMID: 36604599 Review.
[Oxalate: from physiology to pathology].
Grocholski C, Derain Dubourg L, Guebre-Egziabher F, Acquaviva-Bourdain C, Abid N, Bacchetta J, Chambrier C, Lemoine S. Grocholski C, et al. Nephrol Ther. 2023 Jun 19;19(3):201-214. doi: 10.1684/ndt.2023.10. Nephrol Ther. 2023. PMID: 37166780 Review. French.
Primary hyperoxaluria.
Lorenzo V, Torres A, Salido E. Lorenzo V, et al. Nefrologia. 2014 May 21;34(3):398-412. doi: 10.3265/Nefrologia.pre2014.Jan.12335. Epub 2014 Apr 30. Nefrologia. 2014. PMID: 24798559 Free article. Review. English, Spanish.
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2.
Baum MA, Langman C, Cochat P, Lieske JC, Moochhala SH, Hamamoto S, Satoh H, Mourani C, Ariceta G, Torres A, Wolley M, Belostotsky V, Forbes TA, Groothoff J, Hayes W, Tönshoff B, Takayama T, Rosskamp R, Russell K, Zhou J, Amrite A, Hoppe B; PHYOX2 study investigators. Baum MA, et al. Kidney Int. 2023 Jan;103(1):207-217. doi: 10.1016/j.kint.2022.07.025. Epub 2022 Aug 22. Kidney Int. 2023. PMID: 36007597 Free article. Clinical Trial.
Future treatments for hyperoxaluria.
Burns Z, Knight J, Fargue S, Holmes R, Assimos D, Wood K. Burns Z, et al. Curr Opin Urol. 2020 Mar;30(2):171-176. doi: 10.1097/MOU.0000000000000709. Curr Opin Urol. 2020. PMID: 31895888 Free PMC article. Review.
Pathophysiology and management of enteric hyperoxaluria.
Desenclos J, Forté V, Clément C, Daudon M, Letavernier E. Desenclos J, et al. Clin Res Hepatol Gastroenterol. 2024 May;48(5):102322. doi: 10.1016/j.clinre.2024.102322. Epub 2024 Mar 19. Clin Res Hepatol Gastroenterol. 2024. PMID: 38503362 Free article. Review.
Investigational Therapies for Primary Hyperoxaluria.
Kletzmayr A, Ivarsson ME, Leroux JC. Kletzmayr A, et al. Bioconjug Chem. 2020 Jul 15;31(7):1696-1707. doi: 10.1021/acs.bioconjchem.0c00268. Epub 2020 Jun 29. Bioconjug Chem. 2020. PMID: 32539351 Review.
2,008 results